When was Reproline Medical founded?

Reproline Medical was founded in 2000.

Where is Reproline Medical located?

Reproline Medical is headquartered in Rheinbach, Germany.

Which legal entities is Reproline Medical associated with?

Reproline Medical is associated with Reproline medical Society for reproductive medicine, laboratory supplies and med.-techn. Consulting mbH.

Is Reproline Medical a funded company?

Reproline Medical is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Reproline Medical rank among its competitors?

Reproline Medical ranks 30th amongst 25 active competitors, of which 4 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was AutoIVF, which secured $5M in May, 2025.

Who are the top competitors of Reproline Medical?

Reproline Medical's top competitors include INVO Bioscience, AutoIVF and Béa Fertility. Among them, AutoIVF secured the most recent funding round in May, 2025.

Reproline Medical - 2026 Company Profile, Funding & Competitors

Reproline Medical is a funded company based in Rheinbach (Germany), founded in 2000. It operates as a Products portfolio for in-vitro fertility. The company has 25 active competitors, including 4 funded and 2 that have exited. Its top competitors include companies like INVO Bioscience, AutoIVF and Béa Fertility.

Company Details

Reproline Medical produces products for the medical IVF sector. The Company's product portfolio includes a follicle punctuation system, embryo transfer catheters, insemination catheters, micro-glass pipettes and other accessories. eCapital entrepreneurial partners AG completed a Buyback of Reproline Medical in 2014.

Website: reproline-ivf.de
Social

Key Metrics

Founded Year

2000

Location

Rheinbach, Germany

Stage

Funding Raised

Investors

eCAPITAL

Ranked

30^th among 31 competitors

Similar Companies

INVO Bioscience & 29 more

View Reproline Medical's full profile

Reproline Medical is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Reproline medical Society for reproductive medicine, laboratory supplies and med.-techn. Consulting mbH CIN: HRB10589 , Germany, Active	Jan 18, 1998	-	-

Reproline Medical is a funded company. Reproline Medical has 1 institutional investor.

View details of Reproline Medical's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Reproline Medical include INVO Bioscience, AutoIVF and Béa Fertility. Here is the list of Top 10 competitors of Reproline Medical, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	INVO Bioscience 2007, Medford (United States), Public	A medical device company specializing in fertility solutions	-	FOD Capital	56/100
2nd	AutoIVF 2018, Natick (United States), Seed	Developer of solutions to automate and improve In Vitro Fertilization procedures	$5M	Vitrolifegroup, Alpha Edison & 2 others	45/100
3rd	Béa Fertility 2020, London (United Kingdom), Series A	Provider of a device for fertility treatment	$4.31M	Octopus Ventures, Pioneer Group & 23 others	42/100
4th	FertiliTech 2003, Aarhus (Denmark), Acqui-Hired	Develops a technology that improves embryo selection in IVF clinics	$44M	-	38/100
5th	Mosie Baby 2014, Austin (United States), Series A	Artificial insemination solution for women	$1.07M	37 Angels, Magic Fund & 4 others	35/100
6th	Kangaroo Biomedical 2023, San Francisco (United States), Funding Raised	Platform offering artificial reproductive procedures	-	VU Venture Partners	30/100
7th	Anecova 2004, Lausanne (Switzerland), Deadpooled	Provider of assisted reproductive technologies	$5.06M	BV Group	28/100
8th	Baier Rock Series A	Developer of a medical device for assisted reproduction	-	Lenovo Venture Capital Group, Zero2IPO Ventures	28/100
9th	Femiguard 2020, Ra'anana (Israel), Funding Raised	Developer of a medical device for female fertility and sterility	-	Sanara Ventures	27/100
10th	Biorocks 2022, Sha Tin (China), Funding Raised	Provider of medical device for embryo and oocyte preservation	-	Lenovo Capital and Incubator Group	27/100
30th	Reproline Medical 2000, Rheinbach (Germany), Funding Raised	Products portfolio for in-vitro fertility	-	eCAPITAL	15/100